Sponsor:
Nucleix Ltd.
Code:
NCT07514143
Conditions
Suspicion of Bladder Cancer
NMIBC Surveillance
Eligibility Criteria
Sex: All
Age: 22+
Healthy Volunteers: Not accepted
Interventions
Bladder EpiCheck
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-02. This information was provided to ClinicalTrials.gov by Nucleix Ltd. on 2026-04-07.